The Importance of Regular Eye Screenings for Diabetic Retinopathy (Fact Sheet)
This fact sheet explains the importance of regular eye screenings to help detect and treat diabetic retinopathy.
Diabetic Retinopathy
Repeated Ranibizumab Injections Does Not Impair Macular Perfusion
For patients with diabetic macular edema, repeated ranibizumab treatment does not appear to be associated with impaired macular perfusion.
Prevalence of Persistent Diabetic Macular Edema: Bevacizumab vs Aflibercept or Ranibizumab
For patients with diabetic macular edema, persistence is more likely with bevacizumab than with aflibercept or ranibizumab.
Diabetic Retinopathy Risk Increased With Diet Soda Consumption
There was an independent association between high diet soft drink consumption and the likelihood of having proliferative diabetic retinopathy; there was no association seen between regular soda drink consumption and diabetic retinopathy.
Patients With Diabetic Retinopathy Experience Barriers to Diabetes Self-Management
Among Asians, individuals with mild and moderate diabetic retinopathy are more likely to have fallen, and greater perceived barriers to diabetes self-management are associated with the severity of DR in an Asian population.
Efficacy of Anti-VEGF Treatments For Diabetic Retinopathy Explored
Three anti-vascular endothelial growth factor (anti-VEGF) therapies were linked to lowered rates of diabetic retinopathy.
Are RUNX1 Genes Linked to Proliferative Diabetic Retinopathy?
Investigators found a link between the RUNX1 gene and proliferative diabetic retinopathy.
Proliferative Diabetic Retinopathy Outcomes: Ranibizumab vs Retinal Photocoagulation
Cumulative probability of proliferative diabetic retinopathy worsening was 42% in the panretinal photocoagulation group compared with 34% in the ranibizumab group.
Diabetic Macular Edema May Result in Lower Retinal Blood Flow
Patients with diabetic macular edema experienced lower total retinal blood flow than patients without.
AlphaB-Crystallin Levels Tied to Diabetic Retinopathy
Vitreous levels of alphaB-crystallin are significantly higher in eyes of patients with proliferative diabetic retinopathy (PDR) compared with the eyes of controls without diabetes.
